HALO logo
halo search icon
ABVC BioPharma, Inc.

US$1.10

Price Change Indicator
0.00 (0.00%)
ABVC BioPharma, Inc.
ABVC · NAS

ABVC BioPharma, Inc.

Start Trading ABVC for Free

US$1.10

0.00 (0.00%)
20/05/2026 04:00:01 PM
All-CompaniesBig CandleHALO AllHammer Bullish (Realtime)
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

ABVC BioPharma, Inc. Overview

ABVC Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Weak

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About ABVC

icon

Website

ABVC BioPharma, Inc.

icon

Telephone

1.510.668.0881

icon

Address

44370 Old Warm Springs Boulevard, Fremont, CA 94538

Description

ABVC BioPharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development of new drugs and medical devices. The firm's product pipeline includes ABV-1501, which is a combination therapy for triple negative breast cancer, ABV-1504, which is a botanical reuptake inhibitor that targets norepinephrine, ABV-1505 for treating attention deficit hyperactivity disorder, ABV-1702 to treat myelodysplastic syndromes, ABV-1703 for Pancreatic Cancer, ABV-1601 for treating depression in cancer patients, ABV-1701, which is a vitreous substitute for vitrectomy, ABV-2001, and ABV-2002. The company was founded in 1990 and is headquartered in Fremont, CA.

ABVC Price Chart

Key Stats

Market Cap

US$28.60M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.88 - 5.48

Trade Value (12mth)

US$106,251.00

1 week

0.92%

1 month

-13.39%

YTD

-49.77%

1 year

-7.56%

All time high

7163320.00

Key Fundamentals

EPS 3 yr Growth

-92.40%

EBITDA Margin

0.00%

Operating Cashflow

-$3m

Free Cash Flow Return

-42.10%

ROIC

-111.60%

Interest Coverage

-16.00

Quick Ratio

0.40

Other Data

Shares Outstanding (Fully Diluted)

25m

HALO Sector

Healthcare

Next Company Report Date

18-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

ABVC Announcements

Latest Announcements

DateAnnouncements
18 May 26
18 May 26
18 May 26
04 March 26
04 March 26

ABVC Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-1.8-0.42-0.39locklocklock
EPS (Fully Diluted)
 $locklocklocklock-1.8-0.42-0.39locklocklock
Growth
 %locklocklocklock65.476.66.4locklocklock
PE
 XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
 XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of ABVC BioPharma, Inc. (ABVC:NAS)?
Halo FAQ
The current share price of ABVC BioPharma, Inc. (ABVC:NAS) is USD$1.10.
What is the 52-week high share price for ABVC BioPharma, Inc. (ABVC:NAS)?
Halo FAQ
The 52-week high share price for ABVC BioPharma, Inc. (ABVC:NAS) is USD$5.48.
What is the 52-week low share price for ABVC BioPharma, Inc. (ABVC:NAS)?
Halo FAQ
The 52-week low share price for ABVC BioPharma, Inc. (ABVC:NAS) is USD$0.88.
What is the dividend yield for ABVC BioPharma, Inc. (ABVC:NAS)?
Halo FAQ
ABVC BioPharma, Inc. (ABVC:NAS) does not pay a dividend.
What was ABVC BioPharma, Inc. (ABVC:NAS) last dividend payment?
Halo FAQ
ABVC BioPharma, Inc. (ABVC:NAS) does not pay a dividend.
What is the franking level for ABVC BioPharma, Inc. (ABVC:NAS)?
Halo FAQ
ABVC BioPharma, Inc. (ABVC:NAS) has a franking level of 0.00%.
In which sector is ABVC BioPharma, Inc. (ABVC:NAS) classified?
Halo FAQ
ABVC BioPharma, Inc. (ABVC:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial